Galvusmet, a twice-daily combination of vildagliptin and metformin, get listed in national health insurance from this month, according to Novartis Korea and Handok Pharm.
Two strengths of Glavusmet 50/850 mg and 50/1,000 mg are valued at 424 won and 432 won per tablet, respectively.
Vildagliptin is a type of antidiabetic medicine known as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It hel...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.